Oxazepam is a short- to intermediate-acting benzodiazepine indicated for the management of anxiety disorders and for the short-term relief of anxiety symptoms. It is also effective for managing alcohol withdrawal symptoms and is preferred in elderly patients due to its favorable pharmacokinetic profile.
Clinical Overview
Primary Clinical Applications
Oxazepam is indicated for anxiety disorders, short-term anxiety relief, and alcohol withdrawal management. It is particularly valuable in elderly patients and those with hepatic impairment due to its simple metabolic pathway that bypasses hepatic oxidation.
Mechanism and Clinical Benefits
Oxazepam enhances GABA neurotransmission by binding to benzodiazepine receptors, producing anxiolytic, sedative, and anticonvulsant effects. Its conjugation-only metabolism makes it safer in liver disease and elderly patients compared to other benzodiazepines.
Safety Considerations
While generally well-tolerated, oxazepam carries risks of dependence, tolerance, and withdrawal syndrome. It requires careful monitoring for abuse potential and gradual tapering when discontinuing to prevent withdrawal symptoms.
Key Clinical Points
Conjugation-only metabolism
Oxazepam bypasses hepatic oxidation entirely, undergoing direct glucuronidation. This makes it one of the safest benzodiazepines in liver disease and in older adults, alongside lorazepam.
Preferred in alcohol withdrawal with liver impairment
The metabolic route means accumulation is unlikely even where hepatic function is compromised, which is common in this population. No renal dose adjustment is needed either.
Paradoxical reactions in older patients
Agitation and hostility rather than sedation occur more often in elderly patients and are easily misread as worsening of the underlying anxiety.
Contraindicated in myasthenia gravis
Also contraindicated in acute narrow-angle glaucoma, sleep apnoea syndrome, and severe respiratory insufficiency.
Dependence risk persists despite the clean metabolism
Favourable pharmacokinetics do not reduce tolerance, dependence, or withdrawal risk. Gradual tapering is still required. Pregnancy Category D.
Prescribing Information
Dosing & Administration
Anxiety – Mild to Moderate:
- Adults: 10-15 mg 3-4 times daily
Anxiety – Severe/Agitation:
- Adults: 15-30 mg 3-4 times daily
Alcohol Withdrawal:
- Adults: 15-30 mg 3-4 times daily
Elderly/Debilitated:
- Initial: 10 mg 3 times daily
- May increase to: 15 mg 3-4 times daily if needed
Indications
- Anxiety disorders
- Short-term relief of anxiety symptoms
- Alcohol withdrawal symptoms
- Anxiety associated with depression
Contraindications
- Known hypersensitivity to oxazepam or other benzodiazepines
- Acute narrow-angle glaucoma
- Myasthenia gravis
- Severe respiratory insufficiency
- Sleep apnea syndrome
Warnings & Precautions
- Dependence and withdrawal: Risk increases with duration and dose
- CNS depression: Avoid alcohol and other CNS depressants
- Respiratory depression: Use caution in pulmonary disease
- Paradoxical reactions: Agitation, hostility (especially in elderly)
- Suicidal ideation: Monitor in depression
Drug Interactions
- CNS depressants: Enhanced sedation and respiratory depression
- Alcohol: Dangerous potentiation of effects
- Opioids: Increased risk of respiratory depression
- Digoxin: Increased digoxin levels
Adverse Reactions
Common:
- Drowsiness, dizziness, confusion, ataxia
Less Common:
- Headache, vertigo, memory impairment, paradoxical excitement
Special Populations
- Elderly: Preferred benzodiazepine due to simple metabolism
- Hepatic impairment: Safer choice than other benzodiazepines
- Pregnancy: Category D – avoid if possible
- Renal impairment: No dose adjustment needed
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
